Related Experiment Video

Updated: Jul 7, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

DNp73 a matter of cancer: mechanisms and clinical implications

Sven Buhlmann1, Brigitte M Pützer

  • 1Department of Vectorology and Experimental Gene Therapy, Biomedical Research Center, University of Rostock Medical School, Schillingallee 69, 18055 Rostock, Germany.

Biochimica Et Biophysica Acta
|February 28, 2008
PubMed

Insights

The truncated p73 protein (DNp73) drives cancer by inhibiting tumor suppressors. High DNp73 levels correlate with poor prognosis and chemotherapy resistance, highlighting its oncogenic role.

Area of Science:

  • Molecular biology
  • Oncology
  • Cancer research

Background:

  • The p53 protein family regulates critical cellular processes including differentiation, cell cycle arrest, apoptosis, and tumor chemosensitivity.
  • NH2-terminally truncated p73 (DNp73) functions as a potent inhibitor of these tumor suppressor activities, suggesting oncogenic roles in human cancers.

Purpose of the Study:

  • To review recent findings on the oncogenic functions of N-terminally truncated p73 proteins.
  • To elucidate the molecular mechanisms by which DNp73 promotes malignancy.
  • To explore regulatory pathways controlling TP73 isoform expression.

Main Methods:

  • Literature review of recent scientific findings.
  • Analysis of clinical data associating DNp73 expression with cancer characteristics.
  • Investigation of molecular mechanisms underlying DNp73's oncogenic activity.

Main Results:

  • High DNp73 expression is linked to adverse clinico-pathological features in various cancers.
  • Elevated DNp73 levels correlate with treatment failure in chemotherapy.
  • N-terminally truncated p73 proteins are confirmed to be active during oncogenesis.

Conclusions:

  • DNp73 possesses significant oncogenic functions in human tumorigenesis.
  • DNp73 serves as a potential biomarker for disease severity in cancer patients.
  • DNp73 represents a promising therapeutic target for cancer treatment.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...